ÇAVUŞOĞLU, Y. Et Al. 2016. Potential clinical application of LCZ696 in real life clinical practice in heart failure patients who are receiving ACEİ or ARB: Results from REALITY HF Study.. 32. Uluslar arası Katılımlı Türk Kardiyoloji Kongresi, Anatol J Cardiol , (Antalya, Turkey), 2.

ÇAVUŞOĞLU, Y., KOZAN, Ö., TEMİZHAN, A., & KÜÇÜKOĞLU, M. S., (2016). Potential clinical application of LCZ696 in real life clinical practice in heart failure patients who are receiving ACEİ or ARB: Results from REALITY HF Study. . 32. Uluslar arası Katılımlı Türk Kardiyoloji Kongresi, Anatol J Cardiol (pp.2). Antalya, Turkey

ÇAVUŞOĞLU, YÜKSEL Et Al. "Potential clinical application of LCZ696 in real life clinical practice in heart failure patients who are receiving ACEİ or ARB: Results from REALITY HF Study.," 32. Uluslar arası Katılımlı Türk Kardiyoloji Kongresi, Anatol J Cardiol, Antalya, Turkey, 2016

ÇAVUŞOĞLU, YÜKSEL Et Al. "Potential clinical application of LCZ696 in real life clinical practice in heart failure patients who are receiving ACEİ or ARB: Results from REALITY HF Study.." 32. Uluslar arası Katılımlı Türk Kardiyoloji Kongresi, Anatol J Cardiol , Antalya, Turkey, pp.2, 2016

ÇAVUŞOĞLU, Y. Et Al. (2016) . "Potential clinical application of LCZ696 in real life clinical practice in heart failure patients who are receiving ACEİ or ARB: Results from REALITY HF Study.." 32. Uluslar arası Katılımlı Türk Kardiyoloji Kongresi, Anatol J Cardiol , Antalya, Turkey, p.2.

@conferencepaper{conferencepaper, author={YÜKSEL ÇAVUŞOĞLU Et Al. }, title={Potential clinical application of LCZ696 in real life clinical practice in heart failure patients who are receiving ACEİ or ARB: Results from REALITY HF Study.}, congress name={32. Uluslar arası Katılımlı Türk Kardiyoloji Kongresi, Anatol J Cardiol}, city={Antalya}, country={Turkey}, year={2016}, pages={2} }